A tutorial session on the basics of systematic reviews. Covers the the why, how and so what of systematic reviews. Part of a series of public health skills sessions put on for Nottingham City Council Staff.
See linked exercises
This document provides an overview of statistics used in meta-analysis. It discusses key concepts like odds ratios, relative risk, confidence intervals, heterogeneity, and fixed and random effects models. It also summarizes different types of meta-analyses including realist reviews, meta-narrative reviews, and network meta-analyses. Software for performing meta-analyses and potential pitfalls in systematic reviews are also briefly covered.
This document discusses meta-analysis and its use and limitations in synthesizing data from multiple studies on a research question. It notes that while meta-analysis provides an objective means of synthesis, it is still susceptible to biases depending on how it is conducted. Key steps in performing a rigorous meta-analysis are outlined, including having a clear research question, documenting literature search methods, extracting study details, assessing heterogeneity and publication bias, and exploring potential moderators of findings. Concerns raised decades ago about the potential for meta-analyses to be "gamed" remain important to consider.
Network meta-analysis with integrated nested Laplace approximationsBurak Kürsad Günhan
This document discusses network meta-analysis (NMA) models for combining data from multiple treatment comparisons. It provides an overview of NMA terminology and models, including the Lu-Ades and Jackson models. It also demonstrates the application of these models to sample datasets on tuberculosis vaccine trials and smoking cessation interventions using Bayesian inference with integrated nested Laplace approximations (INLA). The key contributions are the INLA implementation of the Jackson NMA model and an R function for fitting various pairwise and network meta-analysis models.
This document provides an overview of meta-analysis, including what it is, why and when it should be conducted, and how to perform one. It defines meta-analysis as using statistical techniques to combine results from multiple studies on a topic to produce a single estimate. It describes when meta-analysis is appropriate, how to assess heterogeneity between studies, account for publication bias, and estimate summary effects. Statistical tests and graphs are presented to evaluate heterogeneity and bias. The document concludes by listing some programs and techniques used for meta-analysis.
This document discusses network meta-analysis (NMA), which synthesizes both direct and indirect evidence from randomized controlled trials (RCTs) that compare multiple interventions. NMA allows for comparisons between interventions that have not been directly compared in RCTs. It provides treatment relative rankings and effect estimates. Assumptions of NMA include similarity of trials, homogeneity within comparisons, and consistency between direct and indirect evidence. Tests for heterogeneity and inconsistency help evaluate if these assumptions are valid. Software like Addis, WinBUGS, NetMetaXL, and RevMan can be used to conduct NMA.
Imran rizvi statistics in meta analysisImran Rizvi
This document discusses statistics used in meta-analyses. It explains that meta-analyses statistically combine results from multiple studies on a topic. Effect measures are calculated for individual studies and then combined to find an overall effect. For dichotomous outcomes, common effect measures are risk ratio, odds ratio, and absolute risk reduction. Random effects models account for heterogeneity between studies, while fixed effect models assume one true effect. Forest plots visually display individual study results and the overall effect, allowing readers to assess consistency and precision.
This document discusses key concepts in biostatistics used in biomedical research. It covers topics like types of variables, measures of central tendency and dispersion, distributions of data, statistical tests for different situations, hypotheses testing and errors, measures of association, diagnostic tests, and regression analysis. Understanding biostatistics is important for evidence-based medicine and improving patient lives through rigorous research. Sample size, confidence intervals, and avoiding bias and confounding are important considerations in study design and interpretation.
This document provides an overview of statistics used in meta-analysis. It discusses key concepts like odds ratios, relative risk, confidence intervals, heterogeneity, and fixed and random effects models. It also summarizes different types of meta-analyses including realist reviews, meta-narrative reviews, and network meta-analyses. Software for performing meta-analyses and potential pitfalls in systematic reviews are also briefly covered.
This document discusses meta-analysis and its use and limitations in synthesizing data from multiple studies on a research question. It notes that while meta-analysis provides an objective means of synthesis, it is still susceptible to biases depending on how it is conducted. Key steps in performing a rigorous meta-analysis are outlined, including having a clear research question, documenting literature search methods, extracting study details, assessing heterogeneity and publication bias, and exploring potential moderators of findings. Concerns raised decades ago about the potential for meta-analyses to be "gamed" remain important to consider.
Network meta-analysis with integrated nested Laplace approximationsBurak Kürsad Günhan
This document discusses network meta-analysis (NMA) models for combining data from multiple treatment comparisons. It provides an overview of NMA terminology and models, including the Lu-Ades and Jackson models. It also demonstrates the application of these models to sample datasets on tuberculosis vaccine trials and smoking cessation interventions using Bayesian inference with integrated nested Laplace approximations (INLA). The key contributions are the INLA implementation of the Jackson NMA model and an R function for fitting various pairwise and network meta-analysis models.
This document provides an overview of meta-analysis, including what it is, why and when it should be conducted, and how to perform one. It defines meta-analysis as using statistical techniques to combine results from multiple studies on a topic to produce a single estimate. It describes when meta-analysis is appropriate, how to assess heterogeneity between studies, account for publication bias, and estimate summary effects. Statistical tests and graphs are presented to evaluate heterogeneity and bias. The document concludes by listing some programs and techniques used for meta-analysis.
This document discusses network meta-analysis (NMA), which synthesizes both direct and indirect evidence from randomized controlled trials (RCTs) that compare multiple interventions. NMA allows for comparisons between interventions that have not been directly compared in RCTs. It provides treatment relative rankings and effect estimates. Assumptions of NMA include similarity of trials, homogeneity within comparisons, and consistency between direct and indirect evidence. Tests for heterogeneity and inconsistency help evaluate if these assumptions are valid. Software like Addis, WinBUGS, NetMetaXL, and RevMan can be used to conduct NMA.
Imran rizvi statistics in meta analysisImran Rizvi
This document discusses statistics used in meta-analyses. It explains that meta-analyses statistically combine results from multiple studies on a topic. Effect measures are calculated for individual studies and then combined to find an overall effect. For dichotomous outcomes, common effect measures are risk ratio, odds ratio, and absolute risk reduction. Random effects models account for heterogeneity between studies, while fixed effect models assume one true effect. Forest plots visually display individual study results and the overall effect, allowing readers to assess consistency and precision.
This document discusses key concepts in biostatistics used in biomedical research. It covers topics like types of variables, measures of central tendency and dispersion, distributions of data, statistical tests for different situations, hypotheses testing and errors, measures of association, diagnostic tests, and regression analysis. Understanding biostatistics is important for evidence-based medicine and improving patient lives through rigorous research. Sample size, confidence intervals, and avoiding bias and confounding are important considerations in study design and interpretation.
This chapter discusses various measures of substantive significance that are important to consider beyond just statistical significance. It covers effect size, which quantifies the size of the difference between groups, and how it is standardized. It also discusses measures used for correlations like r2 and odds ratios for comparing likelihoods between groups. N-of-1 studies are highlighted as important for evaluating significance for individual clients by analyzing changes over time from a baseline. Confidence intervals are also discussed as a way to account for error in measures.
Sample size and how to calculate it
- Why sample size is important
- Alpha and beta errors
- Main outcome and Effect size
- Practical examples using Means-Proportions-Correlation- Confidence Interval
2010 JSM - Meta Stat Issue Medical DevicesTerry Liao
This document summarizes statistical issues that commonly arise in meta-analyses of drug-eluting stent data. It discusses key topics like using fixed effect versus random effects models, strategies for handling zero event rates, and approaches for incorporating time-to-event data like Kaplan-Meier curves. The document provides examples and references to illustrate important considerations for conducting meta-analyses and addressing heterogeneity between studies.
This meta-analysis examined the relationship between body mass index (BMI) and incident asthma. It identified 2006 relevant studies and included 12 prospective cohort studies. Inclusion criteria required adult subjects, asthma as the primary outcome, BMI measurement, minimum 1-year follow up of 70%, and BMI data categorized by standard ranges. Random effects models were used to generate summary odds ratios. Results showed overweight individuals had a 38% higher odds of developing asthma compared to normal weight, and obese individuals had 92% higher odds. When stratified by sex, the association was stronger for women. The analysis provided evidence that higher BMI is a risk factor for incident asthma.
Introduction to evidence based practice slp6030sahughes
This document discusses evidence-based practice in speech-language pathology. It defines evidence-based practice as integrating clinical expertise, patient values, and the best research evidence. Lower levels of research evidence are still useful if they are the best available. Treatment efficacy focuses on controlled studies while effectiveness looks at outcomes under typical clinical conditions. Clinicians should have an open and honest approach when considering different treatment options and be guided by principles of beneficence, autonomy, nonmaleficence, and justice. Forming answerable clinical questions is important to evidence-based practice.
This document provides an overview of how to conduct a systematic review and meta-analysis. It describes the key steps: (1) asking a focused clinical question using PICO, (2) acquiring relevant studies through database searches, (3) appraising the quality of included studies, (4) analyzing the data using statistical methods to obtain an overall treatment effect size, and (5) reporting results typically in a forest plot. Meta-analyses provide increased statistical power over individual studies but are not without limitations such as potential bias that must be considered when interpreting results.
5 essential steps for sample size determination in clinical trials slidesharenQuery
In this free webinar hosted by nQuery Researcher & Statistician Eimear Keyes, we map out the 5 essential steps for sample size determination in clinical trials. At each step, Eimear will highlight the important function it plays and how to avoid the errors that will negatively impact your sample size determination and therefore your study.
Watch the Video: https://www.statsols.com/webinar/the-5-essential-steps-for-sample-size-determination
Meta-analysis is defined as quantitatively combining and integrating the findings of multiple research studies on a particular topic. It was coined by Glass in 1976 and refers to analyzing the results of several studies that address a shared research hypothesis. The key steps in a meta-analysis involve defining a hypothesis, locating relevant studies, inputting empirical data, calculating an overall effect size by standardizing statistics, and analyzing any moderating variables if heterogeneity exists. An example provided is a meta-analysis on coping behaviors of cancer patients that would statistically analyze results from quantitative studies with similar age groups.
1) Meta-analysis is a statistical technique that combines the results of multiple studies on a topic and produces a single estimate of the overall effect. It aims to increase power by pooling data.
2) The first meta-analysis was conducted in 1904, and the term was coined in 1976. Meta-analysis is now often called a "systematic review."
3) Meta-analysis can help clinicians and policymakers integrate research findings and determine if relationships are consistent across studies. It increases precision and statistical power compared to individual studies.
This document discusses parametric and non-parametric statistical tests. It begins by defining different types of data and the standard normal distribution curve. It then covers hypothesis testing, including the different types of errors. Both parametric and non-parametric tests are examined. Parametric tests discussed include z-tests, t-tests, and ANOVA, while non-parametric tests include chi-square, sign tests, McNemar's test, and Fischer's exact test. Examples are provided to illustrate several of the tests.
2.0.statistical methods and determination of sample sizesalummkata1
statistical methods and determination of sample size
These guidelines focus on the validation of the bioanalytical methods generating quantitative concentration data used for pharmacokinetic and toxicokinetic parameter determinations.
P-values the gold measure of statistical validity are not as reliable as many...David Pratap
This is an article that appeared in the NATURE as News Feature dated 12-February-2014. This article was presented in the journal club at Oman Medical College , Bowshar Campus on December, 17, 2015. This article was presented by Pratap David , Biostatistics Lecturer.
This document summarizes a meta-analysis of 206 studies on adventure therapy outcomes published between 1967 and 2012. The meta-analysis found that adventure therapy has a moderate positive effect on psychosocial outcomes, with an overall effect size of 0.50 for pre-post outcomes. Larger effects were found for outcomes related to self-concept, social development, and clinical measures. Moderator analyses found slightly larger effects for older participants and programs with an open group structure. The meta-analysis provides benchmarking data to evaluate adventure therapy program outcomes.
The document provides guidelines for reporting animal research studies in a transparent manner. It outlines the ARRIVE guidelines, which include 10 essential items that should be reported in research papers involving animal subjects. The guidelines aim to improve reproducibility, transparency and quality of reporting. They include reporting the study's objectives and design, the animals used, experimental procedures, and the statistical analysis to allow rigorous assessment of the study. Adhering to these guidelines can help improve communication of research findings.
Choosing appropriate statistical test RSS6 2104RSS6
This document discusses choosing appropriate statistical tests based on study design and data type. It covers descriptive studies that measure prevalence and incidence, as well as analytic studies like randomized controlled trials, cohort studies, and case-control studies. For data type, it discusses approaches for continuous and categorical variables, including t-tests, ANOVA, chi-square tests, and regression. It also discusses measures of disease frequency, effect, and impact like risk difference, risk ratio, and odds ratio.
Non-inferiority and Equivalence Study design considerations and sample sizenQuery
About the webinar
This webinar examines the role of non-inferiority and equivalence in study design
In this free webinar, you will learn about:
-Regulatory information on this type of study design
-Considerations for study design and your sample size
-Practical worked examples of
--Non-inferiority Testing
--Equivalence Testing
Duration - 60 minutes
Speaker: Ronan Fitzpatrick, Head of Statistics, Statsols
Watch the video at: https://www.statsols.com/webinars
This document discusses investigating heterogeneity in meta-analyses through subgroup analysis and meta-regression. It outlines when and how to use these techniques to explore reasons for variability in study results. Key challenges include having enough studies, selecting explanatory variables carefully to avoid false positives, and accounting for confounding and aggregation bias in study-level data. Meta-regression allows for random effects but interpretation requires caution given observational relationships between study characteristics and effects.
The alternating treatments design compares the effects of two or more treatments on a behavior. It answers which treatment is more effective in changing a behavior. Treatments are alternated rapidly to evaluate their relative effects. There are three common variations: with no baseline, baseline followed by alternating treatments, and baseline followed by alternating treatments and a final treatment phase. It is used when determining the relative effectiveness of multiple treatments and baseline data is unavailable or unstable. Disadvantages include a lack of control for extraneous variables and an inability to assess absolute treatment effects.
This document discusses meta-analysis and research synthesis. It begins by explaining the differences between narrative and systematic literature reviews. It then discusses effect sizes and how they are used to quantitatively assess the magnitude of effects across studies, rather than just determining whether an effect exists. The document defines meta-analysis as a statistical tool that combines the results of multiple studies, usually from a systematic review, to produce a summary effect size. Examples of applications and techniques for analysis beyond just the summary effect size are provided, including investigating heterogeneity and performing subgroup and meta-regression analyses. Steps for conducting a meta-analysis are outlined at the end.
Quality assessment in systematic literature reviewJingjing Lin
This tutorial is to introduce the definition, process, and tools of quality assessment in the systematic literature review.
If you are new to my channel, you can check out the previous events together with this one to get started with the systematic literature review as a research approach.
EP11 Systematic Literature Review Planning: workflow, literature scoping, and review protocol (https://youtu.be/qukb-VytjxQ)
EP12 Develop search strategy: fishing relevant literature for your research (https://youtu.be/9cH5I03jbg0)
EP13 Literature screening: inclusion and exclusion
(https://youtu.be/BCdveqka-E4)
You can browse other previous research sharing in this YouTube list of mine (https://www.youtube.com/playlist?list...)
Please kindly subscribe if you want to be reminded when I have new videos published on YouTube.
This chapter discusses various measures of substantive significance that are important to consider beyond just statistical significance. It covers effect size, which quantifies the size of the difference between groups, and how it is standardized. It also discusses measures used for correlations like r2 and odds ratios for comparing likelihoods between groups. N-of-1 studies are highlighted as important for evaluating significance for individual clients by analyzing changes over time from a baseline. Confidence intervals are also discussed as a way to account for error in measures.
Sample size and how to calculate it
- Why sample size is important
- Alpha and beta errors
- Main outcome and Effect size
- Practical examples using Means-Proportions-Correlation- Confidence Interval
2010 JSM - Meta Stat Issue Medical DevicesTerry Liao
This document summarizes statistical issues that commonly arise in meta-analyses of drug-eluting stent data. It discusses key topics like using fixed effect versus random effects models, strategies for handling zero event rates, and approaches for incorporating time-to-event data like Kaplan-Meier curves. The document provides examples and references to illustrate important considerations for conducting meta-analyses and addressing heterogeneity between studies.
This meta-analysis examined the relationship between body mass index (BMI) and incident asthma. It identified 2006 relevant studies and included 12 prospective cohort studies. Inclusion criteria required adult subjects, asthma as the primary outcome, BMI measurement, minimum 1-year follow up of 70%, and BMI data categorized by standard ranges. Random effects models were used to generate summary odds ratios. Results showed overweight individuals had a 38% higher odds of developing asthma compared to normal weight, and obese individuals had 92% higher odds. When stratified by sex, the association was stronger for women. The analysis provided evidence that higher BMI is a risk factor for incident asthma.
Introduction to evidence based practice slp6030sahughes
This document discusses evidence-based practice in speech-language pathology. It defines evidence-based practice as integrating clinical expertise, patient values, and the best research evidence. Lower levels of research evidence are still useful if they are the best available. Treatment efficacy focuses on controlled studies while effectiveness looks at outcomes under typical clinical conditions. Clinicians should have an open and honest approach when considering different treatment options and be guided by principles of beneficence, autonomy, nonmaleficence, and justice. Forming answerable clinical questions is important to evidence-based practice.
This document provides an overview of how to conduct a systematic review and meta-analysis. It describes the key steps: (1) asking a focused clinical question using PICO, (2) acquiring relevant studies through database searches, (3) appraising the quality of included studies, (4) analyzing the data using statistical methods to obtain an overall treatment effect size, and (5) reporting results typically in a forest plot. Meta-analyses provide increased statistical power over individual studies but are not without limitations such as potential bias that must be considered when interpreting results.
5 essential steps for sample size determination in clinical trials slidesharenQuery
In this free webinar hosted by nQuery Researcher & Statistician Eimear Keyes, we map out the 5 essential steps for sample size determination in clinical trials. At each step, Eimear will highlight the important function it plays and how to avoid the errors that will negatively impact your sample size determination and therefore your study.
Watch the Video: https://www.statsols.com/webinar/the-5-essential-steps-for-sample-size-determination
Meta-analysis is defined as quantitatively combining and integrating the findings of multiple research studies on a particular topic. It was coined by Glass in 1976 and refers to analyzing the results of several studies that address a shared research hypothesis. The key steps in a meta-analysis involve defining a hypothesis, locating relevant studies, inputting empirical data, calculating an overall effect size by standardizing statistics, and analyzing any moderating variables if heterogeneity exists. An example provided is a meta-analysis on coping behaviors of cancer patients that would statistically analyze results from quantitative studies with similar age groups.
1) Meta-analysis is a statistical technique that combines the results of multiple studies on a topic and produces a single estimate of the overall effect. It aims to increase power by pooling data.
2) The first meta-analysis was conducted in 1904, and the term was coined in 1976. Meta-analysis is now often called a "systematic review."
3) Meta-analysis can help clinicians and policymakers integrate research findings and determine if relationships are consistent across studies. It increases precision and statistical power compared to individual studies.
This document discusses parametric and non-parametric statistical tests. It begins by defining different types of data and the standard normal distribution curve. It then covers hypothesis testing, including the different types of errors. Both parametric and non-parametric tests are examined. Parametric tests discussed include z-tests, t-tests, and ANOVA, while non-parametric tests include chi-square, sign tests, McNemar's test, and Fischer's exact test. Examples are provided to illustrate several of the tests.
2.0.statistical methods and determination of sample sizesalummkata1
statistical methods and determination of sample size
These guidelines focus on the validation of the bioanalytical methods generating quantitative concentration data used for pharmacokinetic and toxicokinetic parameter determinations.
P-values the gold measure of statistical validity are not as reliable as many...David Pratap
This is an article that appeared in the NATURE as News Feature dated 12-February-2014. This article was presented in the journal club at Oman Medical College , Bowshar Campus on December, 17, 2015. This article was presented by Pratap David , Biostatistics Lecturer.
This document summarizes a meta-analysis of 206 studies on adventure therapy outcomes published between 1967 and 2012. The meta-analysis found that adventure therapy has a moderate positive effect on psychosocial outcomes, with an overall effect size of 0.50 for pre-post outcomes. Larger effects were found for outcomes related to self-concept, social development, and clinical measures. Moderator analyses found slightly larger effects for older participants and programs with an open group structure. The meta-analysis provides benchmarking data to evaluate adventure therapy program outcomes.
The document provides guidelines for reporting animal research studies in a transparent manner. It outlines the ARRIVE guidelines, which include 10 essential items that should be reported in research papers involving animal subjects. The guidelines aim to improve reproducibility, transparency and quality of reporting. They include reporting the study's objectives and design, the animals used, experimental procedures, and the statistical analysis to allow rigorous assessment of the study. Adhering to these guidelines can help improve communication of research findings.
Choosing appropriate statistical test RSS6 2104RSS6
This document discusses choosing appropriate statistical tests based on study design and data type. It covers descriptive studies that measure prevalence and incidence, as well as analytic studies like randomized controlled trials, cohort studies, and case-control studies. For data type, it discusses approaches for continuous and categorical variables, including t-tests, ANOVA, chi-square tests, and regression. It also discusses measures of disease frequency, effect, and impact like risk difference, risk ratio, and odds ratio.
Non-inferiority and Equivalence Study design considerations and sample sizenQuery
About the webinar
This webinar examines the role of non-inferiority and equivalence in study design
In this free webinar, you will learn about:
-Regulatory information on this type of study design
-Considerations for study design and your sample size
-Practical worked examples of
--Non-inferiority Testing
--Equivalence Testing
Duration - 60 minutes
Speaker: Ronan Fitzpatrick, Head of Statistics, Statsols
Watch the video at: https://www.statsols.com/webinars
This document discusses investigating heterogeneity in meta-analyses through subgroup analysis and meta-regression. It outlines when and how to use these techniques to explore reasons for variability in study results. Key challenges include having enough studies, selecting explanatory variables carefully to avoid false positives, and accounting for confounding and aggregation bias in study-level data. Meta-regression allows for random effects but interpretation requires caution given observational relationships between study characteristics and effects.
The alternating treatments design compares the effects of two or more treatments on a behavior. It answers which treatment is more effective in changing a behavior. Treatments are alternated rapidly to evaluate their relative effects. There are three common variations: with no baseline, baseline followed by alternating treatments, and baseline followed by alternating treatments and a final treatment phase. It is used when determining the relative effectiveness of multiple treatments and baseline data is unavailable or unstable. Disadvantages include a lack of control for extraneous variables and an inability to assess absolute treatment effects.
This document discusses meta-analysis and research synthesis. It begins by explaining the differences between narrative and systematic literature reviews. It then discusses effect sizes and how they are used to quantitatively assess the magnitude of effects across studies, rather than just determining whether an effect exists. The document defines meta-analysis as a statistical tool that combines the results of multiple studies, usually from a systematic review, to produce a summary effect size. Examples of applications and techniques for analysis beyond just the summary effect size are provided, including investigating heterogeneity and performing subgroup and meta-regression analyses. Steps for conducting a meta-analysis are outlined at the end.
Quality assessment in systematic literature reviewJingjing Lin
This tutorial is to introduce the definition, process, and tools of quality assessment in the systematic literature review.
If you are new to my channel, you can check out the previous events together with this one to get started with the systematic literature review as a research approach.
EP11 Systematic Literature Review Planning: workflow, literature scoping, and review protocol (https://youtu.be/qukb-VytjxQ)
EP12 Develop search strategy: fishing relevant literature for your research (https://youtu.be/9cH5I03jbg0)
EP13 Literature screening: inclusion and exclusion
(https://youtu.be/BCdveqka-E4)
You can browse other previous research sharing in this YouTube list of mine (https://www.youtube.com/playlist?list...)
Please kindly subscribe if you want to be reminded when I have new videos published on YouTube.
This document discusses meta-analysis, which involves systematically combining results from multiple studies to derive conclusions about a body of research. It describes the key steps in conducting a meta-analysis, including writing a research question and protocol, performing a comprehensive literature search, selecting studies, assessing study quality, extracting data, and analyzing data. Statistical methods for pooling results across studies using fixed and random effects models are also outlined. The document highlights strengths and limitations of meta-analysis for providing more precise estimates of treatment effects and identifying areas needing further research.
The document discusses sample size determination for clinical and epidemiological research. It explains that proper sample size is important for validity, accuracy, and reliability of research findings. Key factors to consider in sample size calculations include the study objective, details of the intervention, outcomes, covariates, research design, and study subjects. Precision analysis and power analysis are two common approaches, with power analysis being most suitable for studies aiming to detect an effect. The document provides formulas and examples for calculating sample sizes for comparative and descriptive studies with both continuous and dichotomous outcomes. It also discusses the concepts of type I and II errors and their relationship to statistical power.
Critical appraisal.docx IMPORTAN TO HEALTH SCIENCE STUDENTSMulugetaAbeneh1
Critical appraisal is the process of systematically examining evidence to assess its validity, results, and relevance before using it to inform decisions. This document discusses tools for critically appraising different types of studies, including systematic reviews, guidelines, and primary studies. It provides examples of appraising systematic reviews using the AMSTAR tool and appraising randomized controlled trials using the JBI critical appraisal checklist. The document concludes that plastic wraps effectively prevent hypothermia in preterm and low birth weight infants compared to standard care, as shown in multiple systematic reviews and randomized trials.
This document provides an introduction to critical appraisal of literature. It discusses the importance of critically evaluating research to separate reliable evidence from unreliable evidence. It outlines the process of critical appraisal, including asking a focused question, finding relevant evidence, and using appraisal tools to systematically examine research quality, validity, and relevance. The document also introduces some key statistical concepts used in research, such as p-values, confidence intervals, risk reduction, and number needed to treat. The goal of critical appraisal is to make informed decisions about integrating research findings into clinical practice and policy.
This document outlines aspects of interpreting quantitative research results. It discusses interpreting results with graphs and diagrams, credibility and different types of biases, magnitude and precision of results, and clinical versus statistical significance. It provides examples of interpreting hypothesized, non-significant, and unhypothesized results. The document emphasizes considering validity, bias, corroboration, and effect sizes when interpreting results as well as implications, generalizability, and significance of findings.
Dr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptxPriyankaSharma89719
The document discusses the importance of biostatistics in biomedical research. It defines clinical research and outlines common issues and questions in biomedical research such as diagnosis, risk factors, and treatment effectiveness. It emphasizes that clinical expertise alone may not improve patient outcomes and that research should be aimed at improving patient lives. The document stresses that all studies should begin with a well-defined research question and overview types of study designs used in clinical research such as observational and interventional studies. It discusses key concepts in research including variables, biases, confounding, and validity and reliability of results.
This document discusses study eligibility criteria and how to set criteria for systematic reviews. It explains that criteria should be tied to the review questions and consider population, intervention, outcomes, timing, and setting. Criteria can be broad to explore what is known or narrow to focus on specific questions, and finding the right balance is important. The document provides examples of how criteria choices can impact applicability and bias reviews by including or excluding certain studies.
Guide for conducting meta analysis in health researchYogitha P
This document discusses meta-analysis and its role in evidence-based dentistry. It defines meta-analysis as the statistical analysis and synthesis of data from multiple scientific studies. Meta-analysis enhances the reliability of conclusions by increasing statistical power and limiting bias compared to individual studies. It can help resolve scientific controversies by establishing whether findings are consistent across studies. The document reviews the steps in conducting a meta-analysis, including developing a clear question and protocol, performing comprehensive literature searches, assessing study quality, extracting outcome data, conducting statistical analyses, and drawing conclusions. It also discusses potential biases and strengths and limitations of meta-analysis.
Practical Methods To Overcome Sample Size ChallengesnQuery
Watch the video at: https://www.statsols.com/webinars/practical-methods-to-overcome-sample-size-challenges
In this webinar hosted by Ronan Fitzpatrick - Head of Statistics and nQuery Lead Researcher at Statsols - we will examine some of the most common practical challenges you will experience while calculating sample size for your study. These challenges will be split into two categories:
1. Overcoming Sample Size Calculation Challenges
(Survival Analysis Example)
We will examine practical methods to overcome common sample size calculation issues by focusing in on one of the more complex areas for sample size determination; Survival analysis. We will cover difficulties and potential issues surrounding challenges such as:
Drop Out: How to deal with expected dropouts or censoring. We compare the simple loss-to-follow-up method and integrating a dropout process into the sample size model?
Planning Uncertainty: How best to deal with the inevitable uncertainty at the planning stage? We examine how best to apply a sensitivity analysis and Bayesian approaches to explore the uncertainty in your sample size calculations.
Choosing the Effect Size: Various approaches and interpretations exist for how to find the effect size value. We examine those contrasting interpretations and determine the best method and also how to deal with parameterization options.
2. Overcoming Study Design Challenges
(Vaccine Efficacy Example)
The Randomised Controlled Trial (RCT) is considered the gold standard in trial design in drug development. However, there are often practical impediments which mean that adjustments or pragmatic approaches are needed for some trials and studies.
We will examine practical methods how to overcome common study design challenges and how these affect your sample size calculations. In this webinar, we will use common issues in vaccine study design to examine difficulties surrounding issues such as:
Case-Control Analysis: We will examine how to deal with study constraints and how to deal with analyses done during an observational study.
Alternative Randomization Methods: How best to address randomization in your vaccine trial design when full randomization is difficult, expensive or impractical. We examine how sample size calculations are affected with cluster or Mendelian randomization.
Rare Events: How does an outcome being rare affect the types of study design and statistical methods chosen in your study.
This document provides an introduction to applied statistics and statistical methods. It discusses objectives such as going beyond the mean and tests of differences like t-tests and ANOVA. It also covers descriptive statistics such as measures of central tendency and dispersion, inferential statistics like z-scores and confidence intervals, and tests of differences including independent and paired t-tests and nonparametric alternatives.
This document discusses key concepts related to sampling and measurement in research. It covers topics such as population and sampling criteria when selecting a sample. It also discusses levels of measurement, reliability, validity, and different measurement strategies like interviews, questionnaires, and scales. Finally, it provides an overview of statistical analysis, including descriptive statistics, levels of measurement, and common statistical tests. The overall purpose is to introduce fundamental concepts for designing research studies and analyzing quantitative data.
The document discusses various threats to valid causal inference from clinical trials, including chance findings, small effect sizes, repeated testing of ineffective treatments, inflation of type 1 error from multiple analyses, non-completion and selective publication of trials, deviations from scientific standards like lack of a comparator, and biases in meta-analyses. It provides examples of how these threats can lead to overstating evidence of effectiveness even when no true causal effect exists. Careful trial design and analysis is needed to avoid these issues and properly assess causality.
This document provides an overview of evidence-based medicine (EBM). It defines EBM as integrating the best available research evidence with clinical expertise and patient values. It notes that the amount of medical evidence is increasing exponentially, making it difficult for physicians to keep up-to-date. The document outlines the 5 steps of EBM practice and emphasizes the importance of critically appraising evidence for validity, importance, and applicability to patients. It also discusses assessing the levels, strength, and quality of evidence to determine the strength of recommendations for clinical practice guidelines.
This document discusses quantitative research approaches, including research methodology, designs, and types. It covers qualitative, quantitative, and mixed methodologies. For research designs, it describes descriptive, correlational, causal-comparative/quasi-experimental, experimental, and mixed designs. The key differences between true experiments and quasi-experiments are also summarized.
1. A frequency distribution is a tabular summary of data showing the frequency or number of items in each of several nonoverlapping classes. The objective is to provide insights about the data that cannot be quickly obtained by looking only at the original data.
2. The document discusses measures of central tendency such as mean, median, and mode. It also discusses measures of dispersion such as range, standard deviation, and coefficient of variation.
3. Hypothesis testing is examined, including the criteria for decision making when the calculated value is compared to the critical value or when using a p-value approach. Type I and Type II errors are also discussed.
Experimental, Quasi experimental, Single-Case, and Internet-based Researches ...Hatice Çilsalar
Experimental, Quasiexperimental, Single-Case Research and Internet based experiments And Article Critique discusses various research designs including experimental, quasi-experimental, single-case, and internet-based experiments. Experimental research uses random assignment and manipulation of independent variables to test causation. Quasi-experimental research lacks random assignment. Single-case research examines the effect of an intervention on an individual subject using repeated measures. Internet-based experiments can reach large, diverse samples but have validity issues like self-selection and dropout. The article provides details on the characteristics, strengths, limitations, and standards for each research design.
The document summarizes a study that examined work-related stress among physicians in primary healthcare (PHC) and hospitals in Bahrain. The study found that hospital physicians reported significantly higher levels of stress than PHC physicians. Stress was also found to be higher among physicians who were younger, male, smokers, and specialists (vs consultants). Sources of stress included high job demands, lack of control, and poor relationships. The study aimed to identify differences in stress levels and factors between PHC and hospital physicians to inform efforts to reduce occupational stress.
Similar to Systematic reviews: Why, How, So what? (20)
The changing landscape of public healthDavid Johns
The document discusses the changing landscape of public health in the UK. It outlines the transition of public health services from the NHS to local authorities in 2012. It then describes the development of integrated care systems across the country from 2015 onward to coordinate health and social care at a local level. The document also provides examples of how public health approaches are being applied within secondary care settings and across wider systems.
Obesity & Nutrition - University of Leicester - Yr 1 Medical studentsDavid Johns
This document references several studies and articles related to childhood obesity and obesity prevention plans. It acknowledges contributions from experts in the field and cites sources from publications like The Lancet, the Journal of Internal Medicine, and the BMJ that discuss topics such as national childhood obesity plans, genetic and environmental factors influencing obesity risk, and the health impacts of obesity.
Childhood Obesity: A whole system approach to eating and moving for good healthDavid Johns
This document summarizes a meeting aimed at bringing together stakeholders to address childhood obesity in Nottingham, UK. The key goals were to understand the various factors influencing children's diet and physical activity, create a network to take a holistic approach, and build a system map showing the relationships between influential factors. The agenda included presentations on local obesity data, systems thinking approaches, and group activities where attendees identified influential factors and built a preliminary system map. The meeting concluded by discussing next steps like combining individual maps and prioritizing joint actions at a follow-up workshop.
This document discusses obesity and its costs. It notes that obesity is defined as excessive fat accumulation that can impair health. It provides statistics on the costs of obesity to the UK NHS (£5.1 billion) and social care (£352 million) as well as costs to the wider economy (£27 billion). It discusses potential factors that contribute to childhood obesity like school environment, social environment, food preferences, culture and attitudes. It also discusses potential local actions that could be taken to address obesity like urban planning, active transportation, access to open spaces and community-led initiatives.
A brief overview for a general healthcare audience on the challenges of nutritional epidemiology, diet and how studies of prevention & treatment are not interchangeable.
Systematic reviews: Why, How, So what? - ExercisesDavid Johns
Exercises for a tutorial session on the basics of systematic reviews. Covers the the why, how and so what of systematic reviews. Part of a series of public health skills sessions put on for Nottingham City Council Staff.
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...Sérgio Sacani
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at 𝐳 = 2.9 wi...Sérgio Sacani
We present the JWST discovery of SN 2023adsy, a transient object located in a host galaxy JADES-GS
+
53.13485
−
27.82088
with a host spectroscopic redshift of
2.903
±
0.007
. The transient was identified in deep James Webb Space Telescope (JWST)/NIRCam imaging from the JWST Advanced Deep Extragalactic Survey (JADES) program. Photometric and spectroscopic followup with NIRCam and NIRSpec, respectively, confirm the redshift and yield UV-NIR light-curve, NIR color, and spectroscopic information all consistent with a Type Ia classification. Despite its classification as a likely SN Ia, SN 2023adsy is both fairly red (
�
(
�
−
�
)
∼
0.9
) despite a host galaxy with low-extinction and has a high Ca II velocity (
19
,
000
±
2
,
000
km/s) compared to the general population of SNe Ia. While these characteristics are consistent with some Ca-rich SNe Ia, particularly SN 2016hnk, SN 2023adsy is intrinsically brighter than the low-
�
Ca-rich population. Although such an object is too red for any low-
�
cosmological sample, we apply a fiducial standardization approach to SN 2023adsy and find that the SN 2023adsy luminosity distance measurement is in excellent agreement (
≲
1
�
) with
Λ
CDM. Therefore unlike low-
�
Ca-rich SNe Ia, SN 2023adsy is standardizable and gives no indication that SN Ia standardized luminosities change significantly with redshift. A larger sample of distant SNe Ia is required to determine if SN Ia population characteristics at high-
�
truly diverge from their low-
�
counterparts, and to confirm that standardized luminosities nevertheless remain constant with redshift.
Candidate young stellar objects in the S-cluster: Kinematic analysis of a sub...Sérgio Sacani
Context. The observation of several L-band emission sources in the S cluster has led to a rich discussion of their nature. However, a definitive answer to the classification of the dusty objects requires an explanation for the detection of compact Doppler-shifted Brγ emission. The ionized hydrogen in combination with the observation of mid-infrared L-band continuum emission suggests that most of these sources are embedded in a dusty envelope. These embedded sources are part of the S-cluster, and their relationship to the S-stars is still under debate. To date, the question of the origin of these two populations has been vague, although all explanations favor migration processes for the individual cluster members. Aims. This work revisits the S-cluster and its dusty members orbiting the supermassive black hole SgrA* on bound Keplerian orbits from a kinematic perspective. The aim is to explore the Keplerian parameters for patterns that might imply a nonrandom distribution of the sample. Additionally, various analytical aspects are considered to address the nature of the dusty sources. Methods. Based on the photometric analysis, we estimated the individual H−K and K−L colors for the source sample and compared the results to known cluster members. The classification revealed a noticeable contrast between the S-stars and the dusty sources. To fit the flux-density distribution, we utilized the radiative transfer code HYPERION and implemented a young stellar object Class I model. We obtained the position angle from the Keplerian fit results; additionally, we analyzed the distribution of the inclinations and the longitudes of the ascending node. Results. The colors of the dusty sources suggest a stellar nature consistent with the spectral energy distribution in the near and midinfrared domains. Furthermore, the evaporation timescales of dusty and gaseous clumps in the vicinity of SgrA* are much shorter ( 2yr) than the epochs covered by the observations (≈15yr). In addition to the strong evidence for the stellar classification of the D-sources, we also find a clear disk-like pattern following the arrangements of S-stars proposed in the literature. Furthermore, we find a global intrinsic inclination for all dusty sources of 60 ± 20◦, implying a common formation process. Conclusions. The pattern of the dusty sources manifested in the distribution of the position angles, inclinations, and longitudes of the ascending node strongly suggests two different scenarios: the main-sequence stars and the dusty stellar S-cluster sources share a common formation history or migrated with a similar formation channel in the vicinity of SgrA*. Alternatively, the gravitational influence of SgrA* in combination with a massive perturber, such as a putative intermediate mass black hole in the IRS 13 cluster, forces the dusty objects and S-stars to follow a particular orbital arrangement. Key words. stars: black holes– stars: formation– Galaxy: center– galaxies: star formation
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDSSérgio Sacani
The pathway(s) to seeding the massive black holes (MBHs) that exist at the heart of galaxies in the present and distant Universe remains an unsolved problem. Here we categorise, describe and quantitatively discuss the formation pathways of both light and heavy seeds. We emphasise that the most recent computational models suggest that rather than a bimodal-like mass spectrum between light and heavy seeds with light at one end and heavy at the other that instead a continuum exists. Light seeds being more ubiquitous and the heavier seeds becoming less and less abundant due the rarer environmental conditions required for their formation. We therefore examine the different mechanisms that give rise to different seed mass spectrums. We show how and why the mechanisms that produce the heaviest seeds are also among the rarest events in the Universe and are hence extremely unlikely to be the seeds for the vast majority of the MBH population. We quantify, within the limits of the current large uncertainties in the seeding processes, the expected number densities of the seed mass spectrum. We argue that light seeds must be at least 103 to 105 times more numerous than heavy seeds to explain the MBH population as a whole. Based on our current understanding of the seed population this makes heavy seeds (Mseed > 103 M⊙) a significantly more likely pathway given that heavy seeds have an abundance pattern than is close to and likely in excess of 10−4 compared to light seeds. Finally, we examine the current state-of-the-art in numerical calculations and recent observations and plot a path forward for near-future advances in both domains.
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...Scintica Instrumentation
Targeting Hsp90 and its pathogen Orthologs with Tethered Inhibitors as a Diagnostic and Therapeutic Strategy for cancer and infectious diseases with Dr. Timothy Haystead.
The debris of the ‘last major merger’ is dynamically youngSérgio Sacani
The Milky Way’s (MW) inner stellar halo contains an [Fe/H]-rich component with highly eccentric orbits, often referred to as the
‘last major merger.’ Hypotheses for the origin of this component include Gaia-Sausage/Enceladus (GSE), where the progenitor
collided with the MW proto-disc 8–11 Gyr ago, and the Virgo Radial Merger (VRM), where the progenitor collided with the
MW disc within the last 3 Gyr. These two scenarios make different predictions about observable structure in local phase space,
because the morphology of debris depends on how long it has had to phase mix. The recently identified phase-space folds in Gaia
DR3 have positive caustic velocities, making them fundamentally different than the phase-mixed chevrons found in simulations
at late times. Roughly 20 per cent of the stars in the prograde local stellar halo are associated with the observed caustics. Based
on a simple phase-mixing model, the observed number of caustics are consistent with a merger that occurred 1–2 Gyr ago.
We also compare the observed phase-space distribution to FIRE-2 Latte simulations of GSE-like mergers, using a quantitative
measurement of phase mixing (2D causticality). The observed local phase-space distribution best matches the simulated data
1–2 Gyr after collision, and certainly not later than 3 Gyr. This is further evidence that the progenitor of the ‘last major merger’
did not collide with the MW proto-disc at early times, as is thought for the GSE, but instead collided with the MW disc within
the last few Gyr, consistent with the body of work surrounding the VRM.
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfSelcen Ozturkcan
Ozturkcan, S., Berndt, A., & Angelakis, A. (2024). Mending clothing to support sustainable fashion. Presented at the 31st Annual Conference by the Consortium for International Marketing Research (CIMaR), 10-13 Jun 2024, University of Gävle, Sweden.
Travis Hills of MN is Making Clean Water Accessible to All Through High Flux ...Travis Hills MN
By harnessing the power of High Flux Vacuum Membrane Distillation, Travis Hills from MN envisions a future where clean and safe drinking water is accessible to all, regardless of geographical location or economic status.
Immersive Learning That Works: Research Grounding and Paths ForwardLeonel Morgado
We will metaverse into the essence of immersive learning, into its three dimensions and conceptual models. This approach encompasses elements from teaching methodologies to social involvement, through organizational concerns and technologies. Challenging the perception of learning as knowledge transfer, we introduce a 'Uses, Practices & Strategies' model operationalized by the 'Immersive Learning Brain' and ‘Immersion Cube’ frameworks. This approach offers a comprehensive guide through the intricacies of immersive educational experiences and spotlighting research frontiers, along the immersion dimensions of system, narrative, and agency. Our discourse extends to stakeholders beyond the academic sphere, addressing the interests of technologists, instructional designers, and policymakers. We span various contexts, from formal education to organizational transformation to the new horizon of an AI-pervasive society. This keynote aims to unite the iLRN community in a collaborative journey towards a future where immersive learning research and practice coalesce, paving the way for innovative educational research and practice landscapes.
The binding of cosmological structures by massless topological defectsSérgio Sacani
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...Sérgio Sacani
Wereport the study of a huge optical intraday flare on 2021 November 12 at 2 a.m. UT in the blazar OJ287. In the binary black hole model, it is associated with an impact of the secondary black hole on the accretion disk of the primary. Our multifrequency observing campaign was set up to search for such a signature of the impact based on a prediction made 8 yr earlier. The first I-band results of the flare have already been reported by Kishore et al. (2024). Here we combine these data with our monitoring in the R-band. There is a big change in the R–I spectral index by 1.0 ±0.1 between the normal background and the flare, suggesting a new component of radiation. The polarization variation during the rise of the flare suggests the same. The limits on the source size place it most reasonably in the jet of the secondary BH. We then ask why we have not seen this phenomenon before. We show that OJ287 was never before observed with sufficient sensitivity on the night when the flare should have happened according to the binary model. We also study the probability that this flare is just an oversized example of intraday variability using the Krakow data set of intense monitoring between 2015 and 2023. We find that the occurrence of a flare of this size and rapidity is unlikely. In machine-readable Tables 1 and 2, we give the full orbit-linked historical light curve of OJ287 as well as the dense monitoring sample of Krakow.
Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...
Systematic reviews: Why, How, So what?
1. David Johns PhD, MPH, RD
Specialty Registrar in Public Health (ST4)
@DavidJohnsRD
2.
3.
4. “A review of a clearly formulated question that uses
systematic and explicit methods to identify, select, and
critically appraise relevant research, and to collect and
analyse data from the studies that are included in the
review...
(Cochrane Collaboration, 2014)
analyse data
12. 1.Defining the
review question(s)
and developing
criteria for
including studies
2. Searching for
studies.
We just
did this bit!
Databases
Search terms
(MeSH)
Grey
literature
Dates
Language
3. Selecting
studies &
collecting data.
Incl/Excl
tools
Get help!
Min 2-3 people
Record
4. Risk of bias
A bit like critical appraisal
See the
Cochrane Risk
of Bias Tool
5. Analyzing data
and undertaking
meta-analyses
We’ll get to
this in a mo…
6. Addressing
reporting bias
Not
everything
gets published
7. Presenting
results
Not really got a
helpful nugget of
info here.
WAIT!
Check out
PRISMA
guidelines.
8. Interpret
results & draw
conclusions
Know it’s
limitations
14. Spot the difference
‘TRADITIONAL’ REVIEWS
One or more
None
Broad w no hypothesis
No search strategy
Not stated
Not stated – subjective
Often narrative
Sometimes influenced by
authors beliefs
Not possible
Not possible
SYSTEMATIC REVIEWS
Two or more
Often published on PROSPERO
Specific incl PICOS. Clear hypothesis
Detailed & comprehensive
Listed
Specific inclusion/exclusion criteria
Narrative, qualitative or quantitative
Drawn from complete evidence base
Yes as accurately documented
Possible – Cochrane annually
Authors:
Protocol:
Research Q:
Search:
Sources:
Selection criteria:
Synthesis:
Conclusions:
Reproducibility:
Update:
16. 0.2 0.5 1.0 2.0 5
Scale for statistic/outcome being
displayed (Odds Ratio/Relative
Risk/Mean difference)
Line of null effect or no
difference
17. 0.2 0.5 1.0 2.0 5
Favours treatment Favours control
95% confidence
interval
Point estimate.
i.e. the study result
Size of the box relates
to the size of the study
18. 0.2 0.5 1.0 2.0 5
Favours treatment Favours control
The important bit!
Point estimate & confidence
interval of combined effect
In this example the
combined effect is
statistically significant
19. 0.2 0.5 1.0 2.0 5
Favours treatment Favours control
The important bit!
Point estimate & confidence
interval of combined effect
In this example the
combined effect is
not statistically significant
20. Study
Treatment
n/N
Control
n/N
Risk Ratio ( 95%CI)
Subtotal 1813 1814 0.78 (0.65-0.94)
Author
Names
and Year
Total Events: x (Treatment), x (Control)
Heterogeneity: Chi2 = 19.21, df = 12 (p=0.08); I2 = 38%
Test for overall effect Z = 3.57 (P = 0.0035)
Focus on I2 for now.
If its < 50%
but above that and
we need to think if
our interventions
are consistent
21.
22. 5.
Limitations
Rubbish IN
-
Rubbish OUT
You can’t compare
the effects of
apples and
carburettors
p.s. I’m really just
talking about
heterogeneity
here
Meta-analysis of
observational study is
still only association!
They can be
out-of-date.
Make sure you look for
what’s been published since!
V
Not to
scale!
There are good
ones and bad
ones. Quality still
counts
24. An invisible unicorn has been grazing in my
office for a month… Prove me wrong.
http://uk.cochrane.org/news/invisible-unicorn-has-been-grazing-my-office-
month%E2%80%A6-prove-me-wrong
No evidence of
effect is not
evidence of no
effect
25. Thanks!
What did I forget?
Please complete the evaluation and next month our FY2
doctor will lead discussion of a systematic review
There are many different study designs, but a Systematic Review is unique. Basically, it’s a study of studies about an intervention. The benefit of the systematic review is that it is a one-stop shop summery of the evidence about a research question. In the Pyramid of Evidence Based Medicine, a Systematic Review of Randomized Control Trials is located at the top; because so many studies are used, it greatly reduces bias.
Unbiased and comprehensive summary and interpretation of current evidence
Increase power (bigger sample sizes),
Improve precision (more confidence)
The PICO process is a technique used in evidence based practice to frame and answer a clinical or health care related question
The PICO process is a technique used in evidence based practice to frame and answer a clinical or health care related question
The PICO process is a technique used in evidence based practice to frame and answer a clinical or health care related question
The PICO process is a technique used in evidence based practice to frame and answer a clinical or health care related question
Don’t try compare oranges and apples
The PICO process is a technique used in evidence based practice to frame and answer a clinical or health care related question
Once a well-defined research question has been established, it is important to outline where you will search for the evidence. Systematic searches should aim to search as many different sources as possible. This can be broken down into…
PsychINFO – key database for mental health literature
MEDLINE – large medical database
EMBASE – large medical database
SCOPUS – includes many scientific disciplines
Cochrane Library – high-quality evidence
Web of Science – includes many scientific disciplines
CINAHL – includes biomedicine, healthcare, nursing and allied health articles
3.
When searching online databases, the terms and their synonyms for each of the components of the PICO model must be written out, including abbreviations. It is also important to use alternate spellings and word endings. This can be done using a number of strategies within the database
Medical Subject Headings (or MeSH terms) are terms predefined by the database using human indexers in concordance with thorough protocols
4. Selection bias; Performance bias; Detection bias; Attrition bias; Reporting bias; Other bias.
My irritation/annoyance at the moment is the rise of editorials being portrayed in the media and by clinicians as new research. They are useful and provide a discussion point for the research community to debate and dissect topics BUT they are not systematic reviews; they do not even include methods. We cannot exclude the possibility of bias including confirmation bias (where you read the stuff that proves your point).
To make a valid decision about using an intervention, ideally we should not rely on the results obtained from single studies. This is because results can vary from one study to another for various reasons, including confounding factors, and the different study samples used.
By combining individual studies, and thus using more data, the precision and accuracy of the estimates in the individual studies can be improved upon. Additionally, if the individual studies were underpowered, combining them in a meta-analysis can increase the overall statistical power to detect an effect.
The horizontal line and whether it crosses the “line of null effect” is particularly important to take note of for each study. If you remember, the incredibly basic definition of the 95% confidence interval is: “The range of values within which you can be 95% certain the true value lies.” If the horizontal line crosses the line of null effect what that is effectively saying is that the null value lies within your confidence interval and hence could be the true value. If I were breaking this down to its most simplest explanation: “any study line which crosses the line of null effect does not illustrate a statistically significant result.”
Note the diamond – what does it represent?
Heterogeneity:
If these studies are all testing the same intervention, why don’t they get the same results? Are the differences caused by chance, or is there something else involved? If it is chance, then we have nothing to worry about. If the differences are not the result of chance, then we need to be cautious in how we interpret the results. To make it easy to assess the consistency of the papers analysed, a statistic called I2 is used (‘i-sqaured’).
The rule of thumb is that you want the I2 to be less than 50%. Anything higher than that and the papers could be inconsistent due to some reason other than chance (which is bad!). For our example, thankfully, the I2 is 38%- not perfect but still within our target range. You will notice there are other statistics there like Chi2 and z. For the purposes of this tutorial, the I2 is the most useful in interpreting a forest plot.
The average takes into account study size when combining results. Bigger studies give more precise results and thus are seen as more important when calculating the combined effect.
Apple’s and carburetors – this is a quote from a Cochrane systematic review course I attended – it is random and extreme but that’s the point. To try rationalize it (which you probably shouldn't), you can’t look at F&V interventions and Air pollution interventions in the same meta-analysis even if they share a common outcome like number of CVD events.
Be critical:
Did the authors look for the right type of papers?
Do you think all the important, relevant studies were included?
Did they assess quality?
See example worksheets with questions…
There is a unicorn on this slide
Funnel plots allow us to visually see where we might be missing studies as you would expect small studies to have large variability on both sides of the line of no effect.
There are a range of statistical methods that can assess the risk of publication bias